Global Vaccine Testing Service Market Strategic Research Report

Scope of the Report

The global Vaccine Testing Service market size is predicted to grow from US$ 4,913 million in 2025 to US$ 8,609 million in 2032; it is expected to grow at a CAGR of 8.4% from 2026 to 2032.

Vaccine testing services are a crucial quality control process ensuring vaccine safety and efficacy. Based on international and national standards, they comprehensively evaluate vaccines through a series of standardized professional tests. This service spans the entire lifecycle of vaccines, from research and development, production, batch release, and post-market surveillance, aiming to guarantee the reliable quality of every dose and provide scientific support for public health security.

The service's industry chain is clear: upstream includes suppliers of testing equipment, reagents, consumables, and standards; midstream consists of core testing service providers, encompassing third-party professional testing institutions, testing institutions under the National Medical Products Administration, and the internal quality control departments of large pharmaceutical companies; downstream, it serves all vaccine research and development and manufacturing companies, ensuring that their products meet all regulatory and quality requirements before being approved for market release and ultimately administered to the public.

The industry has a promising future and is continuously growing with the active global vaccine research and development and increasingly stringent regulatory requirements. Reports show that the global vaccine testing services market reached several billion yuan in 2024 and is expected to maintain steady growth between 2025 and 2031. In the future, the complex processes involved in developing new vaccines will place higher demands on testing, and the application of digital and high-throughput testing technologies will drive the market toward greater efficiency and accuracy.

This report presents a comprehensive overview of the global Vaccine Testing Service market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Physical and Chemical Testing
• Microbial Detection
• Immunological Testing
• Others

Segment by Testing Stages

• Research and Clinical Trial Stage Testing
• Production Quality Control Testing
• Post-Market Surveillance

Segment by Key Testing Items

• Potential Testing
• Safety Testing
• Purity and Sterility Testing
• Others

Segment by Application

• Inactivated Vaccine
• Subunit Vaccine
• Toxoid Vaccine
• mRNA Vaccine
• Viral Vector Vaccine
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Vaccine Testing Service market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Inactivated Vaccine, Subunit Vaccine, Toxoid Vaccine evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact